The clinical importance of SREBP2 has been clearly demonstrated in patients with hypercholesterolemia in whom the treatment with a statin results in the upregulation of the LDL receptor through increased activation of SREBP2. The gene discussed is LDLR; the disease is familial hypercholesterolemia.